Role of Procalcitonin in the Management of Infected Patients in the Intensive Care Unit.

Publication Title

Infectious disease clinics of North America

Document Type

Article

Publication Date

9-1-2017

Keywords

Anti-Bacterial Agents; Antimicrobial Stewardship; Biomarkers; Calcitonin; Community-Acquired Infections; Humans; Intensive Care Units; Molecular Diagnostic Techniques; Multiplex Polymerase Chain Reaction; Pneumonia, Bacterial; Sepsis; Shock, Septic

Abstract

The combination of molecular pathogen diagnostics and the biomarker procalcitonin (PCT) are changing the use of antimicrobials in patients admitted to critical care units with severe community-acquired pneumonia, possible septic shock, or other clinical syndromes. An elevated serum PCT level is good supportive evidence of a bacterial pneumonia, whereas a low serum PCT level virtually eliminates an etiologic role for bacteria even if the culture for a potential bacterial pathogen is positive. Serum PCT levels can be increased in any shocklike state; a low PCT level eliminates invasive bacterial infection as an etiology in more than 90% of patients.

Specialty

Critical Care Medicine

Specialty

Infectious Diseases

Link to Full Text

PSJH Full Text

Share

COinS